mirror of
https://github.com/msberends/AMR.git
synced 2025-07-08 20:02:04 +02:00
(v1.3.0.9006) website update
This commit is contained in:
@ -39,7 +39,7 @@
|
||||
</button>
|
||||
<span class="navbar-brand">
|
||||
<a class="navbar-link" href="../index.html">AMR (for R)</a>
|
||||
<span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Latest development version">1.3.0.9005</span>
|
||||
<span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Latest development version">1.3.0.9006</span>
|
||||
</span>
|
||||
</div>
|
||||
|
||||
@ -320,17 +320,17 @@ Unique: 2</p>
|
||||
<div class="sourceCode" id="cb5"><pre class="downlit">
|
||||
<span class="fu"><a href="https://rdrr.io/r/utils/head.html">head</a></span>(<span class="kw">my_TB_data</span>)
|
||||
<span class="co"># rifampicin isoniazid gatifloxacin ethambutol pyrazinamide moxifloxacin</span>
|
||||
<span class="co"># 1 S S S S S R</span>
|
||||
<span class="co"># 2 S R S R S S</span>
|
||||
<span class="co"># 3 R S S S I R</span>
|
||||
<span class="co"># 4 R S R S R R</span>
|
||||
<span class="co"># 5 R S S R S R</span>
|
||||
<span class="co"># 6 S R I S R S</span>
|
||||
<span class="co"># 1 I S S S S R</span>
|
||||
<span class="co"># 2 S S S R R I</span>
|
||||
<span class="co"># 3 R S S R S I</span>
|
||||
<span class="co"># 4 R S S R S S</span>
|
||||
<span class="co"># 5 S R I R I R</span>
|
||||
<span class="co"># 6 R R S R R R</span>
|
||||
<span class="co"># kanamycin</span>
|
||||
<span class="co"># 1 S</span>
|
||||
<span class="co"># 2 R</span>
|
||||
<span class="co"># 3 R</span>
|
||||
<span class="co"># 4 S</span>
|
||||
<span class="co"># 4 I</span>
|
||||
<span class="co"># 5 R</span>
|
||||
<span class="co"># 6 R</span>
|
||||
</pre></div>
|
||||
@ -368,40 +368,40 @@ Unique: 5</p>
|
||||
<tr class="odd">
|
||||
<td align="left">1</td>
|
||||
<td align="left">Mono-resistant</td>
|
||||
<td align="right">3203</td>
|
||||
<td align="right">64.06%</td>
|
||||
<td align="right">3203</td>
|
||||
<td align="right">64.06%</td>
|
||||
<td align="right">3233</td>
|
||||
<td align="right">64.66%</td>
|
||||
<td align="right">3233</td>
|
||||
<td align="right">64.66%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">2</td>
|
||||
<td align="left">Negative</td>
|
||||
<td align="right">682</td>
|
||||
<td align="right">13.64%</td>
|
||||
<td align="right">3885</td>
|
||||
<td align="right">77.70%</td>
|
||||
<td align="right">698</td>
|
||||
<td align="right">13.96%</td>
|
||||
<td align="right">3931</td>
|
||||
<td align="right">78.62%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">3</td>
|
||||
<td align="left">Multi-drug-resistant</td>
|
||||
<td align="right">627</td>
|
||||
<td align="right">12.54%</td>
|
||||
<td align="right">4512</td>
|
||||
<td align="right">90.24%</td>
|
||||
<td align="right">556</td>
|
||||
<td align="right">11.12%</td>
|
||||
<td align="right">4487</td>
|
||||
<td align="right">89.74%</td>
|
||||
</tr>
|
||||
<tr class="even">
|
||||
<td align="left">4</td>
|
||||
<td align="left">Poly-resistant</td>
|
||||
<td align="right">268</td>
|
||||
<td align="right">5.36%</td>
|
||||
<td align="right">4780</td>
|
||||
<td align="right">95.60%</td>
|
||||
<td align="right">300</td>
|
||||
<td align="right">6.00%</td>
|
||||
<td align="right">4787</td>
|
||||
<td align="right">95.74%</td>
|
||||
</tr>
|
||||
<tr class="odd">
|
||||
<td align="left">5</td>
|
||||
<td align="left">Extensively drug-resistant</td>
|
||||
<td align="right">220</td>
|
||||
<td align="right">4.40%</td>
|
||||
<td align="right">213</td>
|
||||
<td align="right">4.26%</td>
|
||||
<td align="right">5000</td>
|
||||
<td align="right">100.00%</td>
|
||||
</tr>
|
||||
|
Reference in New Issue
Block a user